Preformulation Compatibility Screening of Dika fat-Drug Mixtures Using Differential Scanning Calorimetry
Main Article Content
Abstract
Differential scanning calorimetry (DSC) was used as screening technique for assessing compatibility between dika fat and drug substances. Dika fat was found to be compatible with aspirin, ascorbic acid, paracetamol, sulphanilamide, phenylpropanolamine hydrochloride, bromopheniramine maleate, chlorpheniramire maleate, diazepam, phenobarbital, phenobarbital sodium, phenylpropanolamine hydrochloride and propranolol hydrochloride. It appears that dika fat can be used as a formulation aid in
medicinal or veterinary products containing any of these substances. It was found that dika fat may interact with ephedrine hydrochloride, norgestrel and atropine sulphate.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Balestrieri, F., Magri, A.D., Magri, A.L., Marini, D. and Sacchim, A. (1996). Application of differential scanning calorimeter to the study of drug-excipient compatibility. Thermochimica Acta 285: 337
Botha SA and Lother, AP (1990). Compatibility study between naproxen and tablet excipients udig DSC Drug Dev. Ind. Pharm; 164(4): 673
Bottom, R. (2001) Thermal analysis: Solving problems in the pharmaceutical industry. Pharm Technology Europe November 2001, 37-42
Clarke, E.G.C. Ed. (1969). Isolation and Identification of Drugs, the Pharmaceutical Press, London p. 201
Des Angelis, N. (1969) Analytical Profiles of Drug Substances, Vol. 1, Florey, Ed., Acad. Press, N.Y., pp 302
Donahue J. (1975). Hoffman La Roche, Personal Communication Thro’ Analytical Profiles of Drug Substances, Vol. 1, Florey, Ed., Acad. Press, N.Y., pp 87
El-Shattaway, HH, Kildsig, HH and Peck, GE (1982). Cephalexin-Direct compression excipients: Preformulation stability screening using DSC. Drug Dev. Ind. Pharm. 8(6):897-909
European Pharmacopoeia (1969), Volume 1, Maisonnneuve S.A. France pp 236
Giron, D. (1995) Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates. Thermochim Acta; 248: 1-59
Giron, D. (1998) Contribution of thermal methods and related techniques to the rational development of pharmaceuticals part 1. Pharm sci. Technol Today. 1(5):191-9
McDaid, F.M., Barker, S.A., Fitzpatrick, S., Petts, C.R. and Craig DQM (2003). Further investigations into the use of high sensitivity differential calorimetry as a means of predicting drug-excipient interactions. Int. J. Pharm. 252:235-40
Merck Index (1976a), 9th ed., Merck Co. Inc. N.J. p. 110
Merck Index (1976b), 9th ed., Merck Co. Inc., N.J., p. 868
Mura, P, Faucci, M.T., Manderioli, A., Bramanti and Ceccarelli, L. (1998). Compatibility study between ibuproxam and pharmaceutical excipients using DSC,HSM and SEM J. Pharm. Biom. Anal. 18:151-63
Mura, P., Furlanetto, S., Cirri, M., Maestrelli, F., Marras, A.M. and Pinzauti S (2005). Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and d-optimal mixture experimental design J. Pharm. Biomed. Anal. 37:65-71
Ofoefule, S.I., Chukwu. A., Okore, V.C. and Ugwah, M.O. (1997) Use of dika fat in the formulation of sustained release frusemide encapsulated granules Boll. Chim. Farmaceut 136: 646-650
Ofoefule SI and Chukwu, A (2001). Effects of polyethylene glycol 4000 and sodium lauryl sulphate on the release of hydrochlorothiazide embedded in dika fat matrix. Acta Pharm. 51: 233-239
Onyechi, J.O. and Udeala, O.K. (1990). The tabletting properties of dika fat lubricant Drug Dev. Ind. Pharm. 16(7): 1203-1216
Onyechi, J.O. and Udeala, O.K. (1988). Evaluation of sodium stearoyl-2-lactylate in the formulation of sustained release tablets. Nig. J. Pharm. 19(6): 200-204
Udeala, O.K., Onyechi, J.O. and Agu S.I. (1980). Preliminary evaluation of dika fat a new tablet lubricant. J Pharm Pharmacol. 32: 6-9
Van Doreen, A.A. and Mueller, B.W. (1984). Purity determinations of drugs with differential scanning calorimetry (DSC)- a critical review. Int J Pharm; 20 (3):217-33.